{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Caspofungin+Acetate&page=2", "query": { "intervention": "Caspofungin Acetate", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 25, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Caspofungin+Acetate&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Caspofungin+Acetate&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-02T03:41:13.269Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01869829", "title": "PEACE: Pediatric Antifungal Comparative Effectiveness", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pediatric Invasive Candidiasis" ], "interventions": [ { "name": "Observational antifungal therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "120 Days", "maximum_age": "18 Years", "sex": "ALL", "summary": "120 Days to 18 Years" }, "enrollment_count": 750, "start_date": "2015-01", "completion_date": "2018-04", "has_results": false, "last_update_posted_date": "2022-01-28", "last_synced_at": "2026-10-02T03:41:13.269Z", "location_count": 27, "location_summary": "Little Rock, Arkansas • Orange, California • Palo Alto, California + 24 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Orange", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01869829" }, { "nct_id": "NCT00520234", "title": "Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Invasive Candidiasis" ], "interventions": [ { "name": "Caspofungin", "type": "DRUG" }, { "name": "Normal Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mycoses Study Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 222, "start_date": "2007-08", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2011-05-09", "last_synced_at": "2026-10-02T03:41:13.269Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Los Angeles, California • Denver, Colorado + 8 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00520234" }, { "nct_id": "NCT01503515", "title": "Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fungal Infection", "Hematopoietic and Lymphoid Cell Neoplasm" ], "interventions": [ { "name": "Caspofungin Acetate", "type": "DRUG" }, { "name": "Fluconazole", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Voriconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "20 Years", "sex": "ALL", "summary": "3 Months to 20 Years" }, "enrollment_count": 292, "start_date": "2013-03-21", "completion_date": "2021-09-30", "has_results": true, "last_update_posted_date": "2024-10-16", "last_synced_at": "2026-10-02T03:41:13.269Z", "location_count": 46, "location_summary": "Phoenix, Arizona • Loma Linda, California • Oakland, California + 38 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Loma Linda", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01503515" }, { "nct_id": "NCT00238355", "title": "Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Infection", "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "caspofungin acetate", "type": "DRUG" }, { "name": "voriconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "OHSU Knight Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 13, "start_date": "2003-08", "completion_date": "2008-06", "has_results": true, "last_update_posted_date": "2025-04-27", "last_synced_at": "2026-10-02T03:41:13.269Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00238355" }, { "nct_id": "NCT02734862", "title": "CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Candidemia", "Mycoses", "Fungal Infection", "Fungemia", "Invasive Candidiasis" ], "interventions": [ { "name": "CD101", "type": "DRUG" }, { "name": "Caspofungin", "type": "DRUG" }, { "name": "Fluconazole", "type": "DRUG" }, { "name": "intravenous placebo", "type": "DRUG" }, { "name": "oral placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 207, "start_date": "2016-07-26", "completion_date": "2019-07", "has_results": true, "last_update_posted_date": "2020-12-08", "last_synced_at": "2026-10-02T03:41:13.269Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Davis, California • Miami, Florida + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Davis", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02734862" }, { "nct_id": "NCT04368559", "title": "Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Candidemia", "Mycoses", "Fungal Infection", "Fungemia", "Invasive Candidiasis", "Pneumocystis", "Mold Infection", "Invasive Fungal Disease", "Prophylaxis of Invasive Fungal Infections", "Aspergillus" ], "interventions": [ { "name": "Rezafungin for Injection", "type": "DRUG" }, { "name": "Posaconazole", "type": "DRUG" }, { "name": "Fluconazole", "type": "DRUG" }, { "name": "Trimethoprim-sulfamethoxazole (TMP/SMX)", "type": "DRUG" }, { "name": "Intravenous Placebo", "type": "DRUG" }, { "name": "Oral Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mundipharma Research Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 602, "start_date": "2020-05-11", "completion_date": "2026-01-29", "has_results": false, "last_update_posted_date": "2026-04-13", "last_synced_at": "2026-10-02T03:41:13.269Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Los Angeles, California • Stanford, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04368559" }, { "nct_id": "NCT00805740", "title": "An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Candidiasis", "Fungemia" ], "interventions": [ { "name": "Active anidulafungin", "type": "DRUG" }, { "name": "Active Caspofungin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 41, "start_date": "2009-04", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2013-08-01", "last_synced_at": "2026-10-02T03:41:13.269Z", "location_count": 4, "location_summary": "Newark, Delaware • Wilmington, Delaware • Detroit, Michigan", "locations": [ { "city": "Newark", "state": "Delaware" }, { "city": "Newark", "state": "Delaware" }, { "city": "Wilmington", "state": "Delaware" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00805740" }, { "nct_id": "NCT03667690", "title": "Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Candidemia", "Mycoses", "Fungal Infection", "Invasive Candidiases" ], "interventions": [ { "name": "Rezafungin for Injection", "type": "DRUG" }, { "name": "Caspofungin", "type": "DRUG" }, { "name": "Fluconazole", "type": "DRUG" }, { "name": "intravenous placebo", "type": "DRUG" }, { "name": "oral placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 199, "start_date": "2018-10-07", "completion_date": "2021-10-07", "has_results": true, "last_update_posted_date": "2023-01-06", "last_synced_at": "2026-10-02T03:41:13.269Z", "location_count": 19, "location_summary": "Birmingham, Alabama • Sacramento, California • Atlanta, Georgia + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Sacramento", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03667690" }, { "nct_id": "NCT00005921", "title": "A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Candidiasis, Esophageal", "HIV Infections" ], "interventions": [ { "name": "L-743,872", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "18 Years to 65 Years · Male only" }, "enrollment_count": 18, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-10-02T03:41:13.269Z", "location_count": 1, "location_summary": "Rahway, New Jersey", "locations": [ { "city": "Rahway", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005921" }, { "nct_id": "NCT00723073", "title": "Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Febrile Neutropenia" ], "interventions": [], "intervention_types": [], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 323, "start_date": "2008-01", "completion_date": "2008-05", "has_results": true, "last_update_posted_date": "2010-08-31", "last_synced_at": "2026-10-02T03:41:13.269Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00723073" } ] }